Showing results (221-230 of 693) with videos related to
Sort By:
Pageof 70
Diagnostic Microbiology and Infectious Disease|October 5, 2007
Prevalence of extended-spectrum beta-lactamases in Proteus mirabilis in a Taiwanese university hospital, 1999 to 2005: identification of a novel CTX-M enzyme (CTX-M-66)Jiunn-Jong Wu, Hung-Mo Chen, Wen-Chien Ko, et al.The American Journal of Emergency Medicine|December 30, 2011
Impact of inappropriate empirical antibiotic therapy on outcome of bacteremic adults visiting the EDChing-Chi Lee, Chung-Hsun Lee, Ming-Che Chuang, et al.Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|June 12, 2013
Tigecycline salvage therapy for necrotizing fasciitis caused by Vibrio vulnificus: Case report in a childYu-San Lin, Min-Hsiang Hung, Chi-Chung Chen, et al.Diagnostic Microbiology and Infectious Disease|May 6, 2008
Institutional spread of clonally related Serratia marcescens isolates with a novel AmpC cephalosporinase (S4): a 4-year experience in TaiwanWen-Liang Yu, Wen-Chien Ko, Kuo-Chen Cheng, et al.Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|April 18, 2015
Salmonella infective endocarditisWan-Ling Cheng, Chia-Wen Li, Ming-Chi Li, et al.Antibiotics (Basel, Switzerland)|September 28, 2021
The Potential of Probiotics to Eradicate Gut Carriage of Pathogenic or Antimicrobial-Resistant EnterobacteralesYuan-Pin Hung, Ching-Chi Lee, Jen-Chieh Lee, et al.Journal of Global Antimicrobial Resistance|February 8, 2024
In vitro antimicrobial susceptibility data of global meropenem-resistant Acinetobacter baumannii isolates causing pneumonia: Data from the Antimicrobial Testing Leadership and Surveillance Program, 2014-2021, and re-estimations of susceptibility breakpoints and appropriate dosages of important antibiotics for pneumonia treatmentShun-Chung Hsueh, Yu-Tsung Huang, Wen-Chien Ko, et al.International Journal of Antimicrobial Agents|February 7, 2024
Global trends in nonsusceptibility rates of Escherichia coli isolates to meropenem and ceftazidime/avibactam: Data from the Antimicrobial Testing Leadership and Surveillance (ATLAS) programme, 2014-21Jiun-Ling Wang, Chih-Cheng Lai, Ya-Wen Tsai, et al.Pharmaceutics|November 27, 2021
Advances in the Application of Nanomaterials as Treatments for Bacterial Infectious DiseasesYuan-Pin Hung, Yu-Fon Chen, Pei-Jane Tsai, et al.Antimicrobial Agents and Chemotherapy|June 25, 2003
In vitro and in vivo activities of fluoroquinolones against Aeromonas hydrophilaWen-Chien Ko, Shyh-Ren Chiang, Hsin-Chun Lee, et al.Pageof 70